Biotech

All Articles

ArsenalBio raises $325M, turns off of previous lead possession

.Toolbox Biosciences is moving on up. The cell therapy business has added on $325 thousand in ammuni...

Lilly- backed weight loss biotech reports IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has actually fi...

Aelis' marijuana usage medicine flunks stage 2b, steering Indivior to re-think $100M alternative

.Aelis Farma's chances of safeguarding an easy, beneficial decision on a $one hundred million choice...

ProKidney stops stage 3 trial certainly not needed for tissue treatment authorization

.ProKidney has stopped one of a set of period 3 trials for its own cell therapy for renal illness af...

Vaxcyte surges on 'impressive' 31-valent PCV win against Pfizer

.Vaxcyte revealed what experts named "spectacular" phase 1/2 information for its own 31-valent pneum...

Recursion's mind illness trial reveals insufficient documentation of effectiveness

.Recursion has stumbled with a very early examination of its own tech-enabled strategy to medicine e...

Acepodia, Pfizer click on together for chemistry-based tissue therapy

.Contact it a scenario of really good chemical make up: Acepodia, a biotech based on Nobel Champion ...

Praxis epilepsy medication lessens seizures in stage 2 litigation

.Practice Preciseness Medicines has actually scored an additional midphase gain in epilepsy this yea...

Three officers resign as Dyne articles mixed records for DMD prospect

.After running away a scientific grip numerous years back, Dyne Therapeutics has actually shown bran...

Arrowhead fires off phase 3 data in rare metabolic health condition in front of market encounter Ionis

.Arrowhead Pharmaceuticals has shown its own give before a potential face-off along with Ionis, publ...